Evaluation of rapid low-cost colorimetric methods for diagnosis of multidrug-resistant tuberculosis in limited-resource settings
暂无分享,去创建一个
[1] P. Andersen,et al. The success and failure of BCG — implications for a novel tuberculosis vaccine , 2005, Nature Reviews Microbiology.
[2] J. Musser,et al. Sequence-Based Identification ofMycobacterium Species Using the MicroSeq 500 16S rDNA Bacterial Identification System , 2000, Journal of Clinical Microbiology.
[3] S. Cole,et al. Differential Effects of Prior Exposure to Environmental Mycobacteria on Vaccination with Mycobacterium bovis BCG or a Recombinant BCG Strain Expressing RD1 Antigens , 2005, Infection and Immunity.
[4] R. Cooksey,et al. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[5] M. Dimairo,et al. Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[6] P. Vandamme,et al. A new rapid and simple colorimetric method to detect pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide. , 2006, The Journal of antimicrobial chemotherapy.
[7] F. Portaels,et al. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[8] Hansjakob Furrer,et al. Effect of Mutation and Genetic Background on Drug Resistance in Mycobacterium tuberculosis , 2012, Antimicrobial Agents and Chemotherapy.
[9] T D McHugh,et al. Prospective evaluation of BDProbeTec strand displacement amplification (SDA) system for diagnosis of tuberculosis in non-respiratory and respiratory samples. , 2004, Journal of medical microbiology.
[10] R. Wilkinson,et al. The clinical consequences of strain diversity in Mycobacterium tuberculosis. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[11] W. Lester. Treatment of drug-resistant tuberculosis. , 1971, Disease-a-month : DM.
[12] C. Leung,et al. Management of multidrug‐resistant tuberculosis: Update 2007 , 2007, Respirology.
[13] D. Spandidos,et al. Molecular diagnostic tools in mycobacteriology. , 2008, Journal of microbiological methods.
[14] S. Kaufmann,et al. Mycobacterium tuberculosis: success through dormancy. , 2012, FEMS microbiology reviews.
[15] M. Pai,et al. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. , 2010, The Lancet. Infectious diseases.
[16] M. Pai,et al. Diagnosis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: Current standards and challenges. , 2008, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.
[17] Peter Eaton,et al. Gold nanoparticles for the development of clinical diagnosis methods , 2008, Analytical and bioanalytical chemistry.
[18] N. Pollock,et al. Identification of Mycobacterium tuberculosis Ornithine Carboamyltransferase in Urine as a Possible Molecular Marker of Active Pulmonary Tuberculosis , 2008, Clinical and Vaccine Immunology.
[19] D. Moore,et al. Alternative methods of diagnosing drug resistance--what can they do for me? , 2011, The Journal of infectious diseases.
[20] M. Drancourt,et al. Diagnosis of pulmonary tuberculosis in a microbiological laboratory. , 2011, Medecine et maladies infectieuses.
[21] Rosella Centis,et al. INVITED REVIEW SERIES: TUBERCULOSIS , 2010 .
[22] E. Stella,et al. Comparison of the Performances of Two In-House Rapid Methods for Antitubercular Drug Susceptibility Testing , 2008, Antimicrobial Agents and Chemotherapy.
[23] S. Franzblau,et al. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[24] L. Lindquist,et al. Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[25] A. Aseffa,et al. Evaluation of a direct colorimetric assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis , 2005 .
[26] N. Pollock,et al. Identification and characterization of Mycobacterium tuberculosis antigens in urine of patients with active pulmonary tuberculosis: an innovative and alternative approach of antigen discovery of useful microbial molecules , 2008, Clinical and experimental immunology.
[27] Anandi Martin,et al. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[28] Pratibha Sharma,et al. Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis. , 2012, Journal of microbiological methods.
[29] J. O’Grady,et al. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis , 2011, Current opinion in pulmonary medicine.
[30] J. Caminero,et al. Management of multidrug-resistant tuberculosis: an update , 2010, Therapeutic advances in respiratory disease.
[31] D. Berg,et al. Rapid, Efficient Detection and Drug Susceptibility Testing of Mycobacterium tuberculosis in Sputum by Microscopic Observation of Broth Cultures , 2000, Journal of Clinical Microbiology.
[32] D. van Soolingen. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements , 2001, Journal of internal medicine.
[33] C. Griffiths,et al. Diagnosis of active and latent tuberculosis: summary of NICE guidance , 2012, BMJ : British Medical Journal.
[34] F. Portaels,et al. Evaluation of the resazurin assay for the detection of multidrug-resistant Mycobacterium tuberculosis in Madagascar. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[35] F. Portaels,et al. Thin-layer agar for detection of resistance to rifampicin, ofloxacin and kanamycin in Mycobacterium tuberculosis isolates. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[36] Evaluation of the Cobas TaqMan MTB Test for Direct Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens , 2010, Journal of Clinical Microbiology.
[37] Pedro Barquinha,et al. Gold on paper-paper platform for Au-nanoprobe TB detection. , 2012, Lab on a chip.
[38] A. R. Escombe,et al. Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB , 2008 .
[39] S. Kalantri,et al. New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance , 2006, Expert review of molecular diagnostics.
[40] F. Q. Falconi,et al. Comparison of the VersaTREK system and Löwenstein-Jensen medium for the recovery of mycobacteria from clinical specimens , 2008, Scandinavian journal of infectious diseases.
[41] A. Van Deun,et al. Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[42] E. Lemma,et al. Evaluation of Microscopic Observation Drug Susceptibility Assay for Detection of Multidrug-Resistant Mycobacterium tuberculosis , 2007, Journal of Clinical Microbiology.
[43] F. Portaels,et al. Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. , 2007, The Journal of antimicrobial chemotherapy.
[44] G. Roberts,et al. Evaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test by Using Respiratory and Nonrespiratory Specimens in a Tertiary Care Center Laboratory , 2002, Journal of Clinical Microbiology.
[45] V. Lorian. Bailey & Scott's Diagnostic Microbiology , 1990 .
[46] F. Portaels,et al. Rapid and Inexpensive Detection of Multidrug-Resistant Mycobacterium tuberculosis with the Nitrate Reductase Assay Using Liquid Medium and Direct Application to Sputum Samples , 2008, Journal of Clinical Microbiology.
[47] A. Kilic. Advances in the Diagnosis of Mycobacterium tuberculosis and Detection of Drug Resistance , 2013 .
[48] Alimuddin Zumla,et al. Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments , 2010, Current opinion in pulmonary medicine.
[49] T. Shinnick,et al. Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[50] M. Joloba,et al. Direct Nitrate Reductase Assay versus Microscopic Observation Drug Susceptibility Test for Rapid Detection of MDR-TB in Uganda , 2011, PloS one.
[51] Jacques Theron,et al. Selection and Application of ssDNA Aptamers to Detect Active TB from Sputum Samples , 2012, PloS one.
[52] P. Baptista,et al. Gold-nanoparticle-probe-based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. , 2006, Clinical chemistry.
[53] R. Prasad,et al. Multi-drug resistant tuberculosis: an iatrogenic problem. , 2010, Bioscience trends.
[54] M. Joloba,et al. Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban Kampala, Uganda , 2008, BMC infectious diseases.
[55] B. Barrell,et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.
[56] Robert H. Gilman,et al. Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay , 1998, Journal of Clinical Microbiology.
[57] J. Palomino,et al. Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis. , 2011, The Journal of antimicrobial chemotherapy.
[58] M. Amicosante,et al. Evaluation of the BDProbeTec strand displacement amplification assay in comparison with the AMTD II direct test for rapid diagnosis of tuberculosis. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[59] F. Portaels,et al. The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. , 2008, The Journal of antimicrobial chemotherapy.
[60] F. Portaels,et al. Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis , 2002, Antimicrobial Agents and Chemotherapy.
[61] J. Palomino. Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis. , 2009, FEMS immunology and medical microbiology.
[62] M. Thakur,et al. Global tuberculosis control report. , 2001, The National medical journal of India.
[63] Tanya Parish,et al. Mycobacteria Protocols , 2009, Methods in Molecular Biology.
[64] J. O’Grady,et al. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. , 2012, The Journal of infectious diseases.
[65] N. Kalyan,et al. Rapid, inexpensive MIC determination of Mycobacterium tuberculosis isolates by using microplate nitrate reductase assay. , 2005, Diagnostic microbiology and infectious disease.
[66] K. Steingart,et al. Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review , 2007, PLoS medicine.
[67] A. Fathy,et al. Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial , 2009, Annals of Clinical Microbiology and Antimicrobials.
[68] A. Orcau,et al. Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona. , 2010, The Journal of antimicrobial chemotherapy.
[69] M. Siedner,et al. Inter- and Intra-Assay Reproducibility of Microplate Alamar Blue Assay Results for Isoniazid, Rifampicin, Ethambutol, Streptomycin, Ciprofloxacin, and Capreomycin Drug Susceptibility Testing of Mycobacterium tuberculosis , 2008, Journal of Clinical Microbiology.
[70] Falk Hildebrand,et al. Origin, Spread and Demography of the Mycobacterium tuberculosis Complex , 2008, PLoS pathogens.
[71] F. Portaels,et al. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis. , 2008, Journal of microbiological methods.
[72] R. Chaisson,et al. Diagnostic Accuracy of a Urine Lipoarabinomannan Test for Tuberculosis in Hospitalized Patients in a High HIV Prevalence Setting , 2009, Journal of acquired immune deficiency syndromes.
[73] M. Schoenfisch,et al. Analytical chemistry of nitric oxide. , 2009, Annual review of analytical chemistry.
[74] K. Carroll,et al. of Tuberculosis in Low-Prevalence Settings Laboratory in Diagnosis and Management Role of the Clinical Mycobacteriology , 2011 .
[75] S. Hoffner,et al. Rapid and Inexpensive Drug Susceptibility Testing of Mycobacterium tuberculosis with a Nitrate Reductase Assay , 2002, Journal of Clinical Microbiology.
[76] S. Cole,et al. Mechanisms of drug resistance in Mycobacterium tuberculosis. , 1994, Immunobiology.
[77] G. Sandhu,et al. Tuberculosis: Current Situation, Challenges and Overview of its Control Programs in India , 2011, Journal of global infectious diseases.
[78] G. Nataraj,et al. Rapid antibiotic susceptibility testing of Mycobacterium tuberculosis: its utility in resource poor settings. , 2006, Indian journal of medical microbiology.
[80] L. P. Ormerod. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. , 2005, British medical bulletin.
[81] M. Joloba,et al. Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis , 2009, BMC infectious diseases.
[82] J. Nkengasong,et al. Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities , 2011, Clinical Microbiology Reviews.
[83] R. Brosch,et al. Pathogenicity in the tubercle bacillus: molecular and evolutionary determinants , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.
[84] G. Cangelosi,et al. Drug Resistance Assays for Mycobacterium tuberculosis , 2009 .
[85] I. Khan,et al. Microplate nitrate reductase assay versus Alamar Blue assay for MIC determination of Mycobacterium tuberculosis. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[86] Enrico Tortoli,et al. Evaluation of INNO-LiPA MYCOBACTERIA v2: Improved Reverse Hybridization Multiple DNA Probe Assay for Mycobacterial Identification , 2003, Journal of Clinical Microbiology.
[87] S. Abbott,et al. 16S rRNA Gene Sequencing for Bacterial Identification in the Diagnostic Laboratory: Pluses, Perils, and Pitfalls , 2007, Journal of Clinical Microbiology.
[88] Zhong-yi Hu,et al. Interferon-gamma release assays for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. , 2012, FEMS immunology and medical microbiology.
[89] E. Böttger,et al. Differentiation of Mycobacterium species by direct sequencing of amplified DNA. , 1990, Journal of general microbiology.
[90] J. Palomino,et al. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. , 2011, The Journal of antimicrobial chemotherapy.
[91] B. Bjorvatn,et al. Rapid Colorimetric Method for Testing Susceptibility of Mycobacterium tuberculosis to Isoniazid and Rifampin in Liquid Cultures , 2003, Journal of Clinical Microbiology.
[92] E. Böttger,et al. Tuberculosis: drug resistance, fitness, and strategies for global control , 2008, European Journal of Pediatrics.
[93] Zhi-ping Zhang,et al. Multiplex Detection of Mutations in Clinical Isolates of Rifampin-Resistant Mycobacterium tuberculosis by Short Oligonucleotide Ligation Assay on DNA Chips , 2004, Journal of Clinical Microbiology.
[94] Karin Weyer,et al. Viewpoint TB diagnostics: what does the world really need? , 2011, The Journal of infectious diseases.
[95] L. O’Connor. Diagnostic Bacteriology Protocols , 2006, Methods in Molecular Biology™.
[96] C. Saltini. Chemotherapy and diagnosis of tuberculosis. , 2006, Respiratory medicine.
[97] C. Spreadbury. Mycobacteria, Molecular Biology and Virulence , 2001 .
[98] P. Woo,et al. Guidelines for interpretation of 16S rRNA gene sequence-based results for identification of medically important aerobic Gram-positive bacteria. , 2009, Journal of medical microbiology.
[99] J. Palomino,et al. Tuberculosis 2007; from basic science to patient care , 2007 .
[100] F. Portaels,et al. Rapid drug resistance detection in Mycobacterium tuberculosis: a review of colourimetric methods. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[101] Wilbert Bitter,et al. Type VII secretion — mycobacteria show the way , 2007, Nature Reviews Microbiology.
[102] G. Kahlmeter,et al. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis. , 2009, The Journal of antimicrobial chemotherapy.
[103] F. Portaels,et al. Practical handbook for the phenotypic and genotypic identification of mycobacteria , 2004 .
[104] H. McShane,et al. Tuberculosis vaccines: progress and challenges. , 2011, Trends in pharmacological sciences.
[105] B. Robertson,et al. Mycobacterium tuberculosis Lineage Influences Innate Immune Response and Virulence and Is Associated with Distinct Cell Envelope Lipid Profiles , 2011, PloS one.
[106] J. Palomino,et al. Multicentre study of nitrate reductase assay for rapid detection of rifampicin-resistant M. tuberculosis. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[107] E. Böttger. The ins and outs of Mycobacterium tuberculosis drug susceptibility testing. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[108] Suhail Ahmad,et al. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. , 2009, Respiratory medicine.
[109] M. Pai,et al. Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[110] Y. Balabanova,et al. Diagnosis of tuberculosis and drug resistance: what can new tools bring us? , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[111] G. Kahlmeter,et al. Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis. , 2012, Bulletin of the World Health Organization.
[112] N. Smith,et al. Myths and misconceptions: the origin and evolution of Mycobacterium tuberculosis , 2009, Nature Reviews Microbiology.
[113] Nancy A Knechel. Tuberculosis: pathophysiology, clinical features, and diagnosis. , 2009, Critical care nurse.
[114] John W. Wilson,et al. Update on the treatment of tuberculosis. , 2008, American family physician.
[115] Z LEVNTAL,et al. [History of tuberculosis]. , 1957, Medicinski glasnik.
[116] M. Pai,et al. Bacteriophage assays for rifampicin resistance detection in Mycobacterium tuberculosis: updated meta-analysis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[117] D. Mitchison. The diagnosis and therapy of tuberculosis during the past 100 years. , 2005, American journal of respiratory and critical care medicine.
[118] S. Kalantri,et al. New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis , 2006, Expert review of molecular diagnostics.
[119] Priscille Brodin,et al. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti , 2002, Molecular microbiology.
[120] J. Sáez-Nieto,et al. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical strains isolated in the Philippines. , 2004, International journal of antimicrobial agents.
[121] Zeinab H. Helal,et al. Unexpectedly High Proportion of Ancestral Manu Genotype Mycobacterium tuberculosis Strains Cultured from Tuberculosis Patients in Egypt , 2009, Journal of Clinical Microbiology.
[122] M. Perkins,et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. , 2006, The Lancet. Infectious diseases.
[123] D. Alland,et al. A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria. , 2007, Journal of microbiological methods.
[124] B. Marston,et al. Interferon-Gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in HIV-Infected Individuals: A Systematic Review and Meta-Analysis , 2011, Journal of acquired immune deficiency syndromes.
[125] J. Palomino,et al. Current developments and future perspectives for TB diagnostics. , 2012, Future microbiology.